Regenicin, Inc. Deferred Tax Assets, Net of Valuation Allowance, Current
Regenicin, Inc. had Deferred Tax Assets, Net of Valuation Allowance, Current of $863.30 thousand as of 2014-12-31, per its 10-Q filed 2015-02-23.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2016-01-13
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $863.30K.
- 2014-09-30: Deferred Tax Assets, Net of Valuation Allowance, Current $2.83M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2014-12-31 | $863.30K 10-Q · filed 2015-02-23 |
| 2014-09-30 | $2.83M 10-K · filed 2016-01-13 |